Article
Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
International journal of laboratory hematology - 1 Oct 2011
Nadarajan V, Shanmugam H, Sthaneshwar P, Jayaranee S, Sultan K S, Ang C, Arumugam S
Abstract excerpt
INTRODUCTION: The glucose-6-phosphate dehydrogenase (G6PD) fluorescent spot test (FST) is a useful screening test for G6PD deficiency, but is unable to detect heterozygote G6PD-deficient females. We sought to identify whether reporting intermediate fluorescence in addition to absent and bright fluorescence on FST would improve identification of mildly deficient female heterozygotes. METHODS: A total of 1266 cord...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.